Research progress on risk factors of coronary slow flow

LI Jinpei; WANG Yonghuai; LI Guangyuan; MA Chunyan; YANG Jun

doi:10.7619/jcmp.20220353

Journal of Clinical Medicine in Practice > 2022 > 26(12): 115-118. > DOI: 10.7619/jcmp.20220353

LI Jinpei, WANG Yonghuai, LI Guangyuan, MA Chunyan, YANG Jun. Research progress on risk factors of coronary slow flow[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 115-118. DOI: 10.7619/jcmp.20220353

Citation:

PDF (539 KB)

Research progress on risk factors of coronary slow flow

Department of Cardiovascular Ultrasound, the First Hospital Affiliated to China Medical University, Shenyang, Liaoning, 110001

More Information

Received Date: January 28, 2022
Available Online: June 21, 2022

Graphical Abstract

Abstract

Abstract

In coronary angiography, the phenomenon of delayed filling and emptying of contrast agent without obvious stenosis of coronary artery is called coronary slow flow(CSF), which is clinically manifested by recurrent chest pain and even leads to other adverse cardiovascular events that seriously affect patients′quality of life, thus it has caused widespread clinical concern. This paper reviewed the risk factors of CSF, aiming to provide a reference for the pathogenesis research and clinical diagnosis and treatment of CSF.
- coronary slow flow,
- risk factors,
- atherosclerosis,
- chest pain,
- myocardial infarction,
- malignant arrhythmia

FullText(HTML)

References (33)

References

[1]	TAMBE A A, DEMANY M A, ZIMMERMAN H A, et al. Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding[J]. Am Heart J, 1972, 84(1): 66-71. doi: 10.1016/0002-8703(72)90307-9
[2]	HAWKINS B M, STAVRAKIS S, ROUSAN T A, et al. Coronary slow flow-prevalence and clinical correlations[J]. Circ J, 2012, 76(4): 936-942. doi: 10.1253/circj.CJ-11-0959
[3]	GIBSON C M, CANNON C P, DALEY W L, et al. TIMI frame count: a quantitative method of assessing coronary artery flow[J]. Circulation, 1996, 93(5): 879-888. doi: 10.1161/01.CIR.93.5.879
[4]	SANGHVI S, MATHUR R, BAROOPAL A, et al. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: a single centre experience[J]. Indian Heart J, 2018, 70(Suppl 3): S290-S294.
[5]	SANATI H, KIANI R, SHAKERIAN F, et al. Coronary slow flow phenomenon clinical findings and predictors[J]. Res Cardiovasc Med, 2016, 5(1): e30296.
[6]	CELEBI H, CATAKOGLU A B, KURTOGLU H, et al. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries[J]. Cardiovasc Revasc Med, 2008, 9(3): 144-148. doi: 10.1016/j.carrev.2007.11.002
[7]	MCEVOY J W, NASIR K, DEFILIPPIS A P, et al. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2015, 35(4): 1002-1010. doi: 10.1161/ATVBAHA.114.304960
[8]	RIZA ERBAY A, TURHAN H, YASAR A S, et al. Elevated level of plasma homocysteine in patients with slow coronary flow[J]. Int J Cardiol, 2005, 102(3): 419-423. doi: 10.1016/j.ijcard.2004.05.064
[9]	YUCEL H, OZAYDIN M, DOGAN A, et al. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow[J]. Scand J Clin Lab Investig, 2012, 72(6): 495-500. doi: 10.3109/00365513.2012.699637
[10]	ALTUN I, AKIN F, KOSE N, et al. Predictors of slow flow in angiographically normal coronary arteries[J]. Int J Clin Exp Med, 2015, 8(8): 13762-13768.
[11]	WANG S, ZHANG Y Y, CHENG Y T, et al. Correlation between the hematocrit and slow coronary flow[J]. Clin Hemorheol Microcirc, 2014, 58(2): 297-305. doi: 10.3233/CH-121659
[12]	LUO S H, JIA Y J, NIE S P, et al. Increased red cell distribution width in patients with slow coronary flow syndrome[J]. Clin Sao Paulo Braz, 2013, 68(6): 732-737. doi: 10.6061/clinics/2013(06)02
[13]	CETIN M S, OZCAN CETIN E H, CANPOLAT U, et al. An overlooked parameter in coronary slow flow phenomenon: whole blood viscosity[J]. Biomark Med, 2015, 9(12): 1311-1321. doi: 10.2217/bmm.15.92
[14]	SEYYED-MOHAMMADZAD M H, KHADEMVATANI K, KERACHIAN A, et al. Slow coronary flow phenomenon and increased platelet volume indices[J]. Korean Circ J, 2014, 44(6): 400-405. doi: 10.4070/kcj.2014.44.6.400
[15]	AKBOGA M K, CANPOLAT U, BALCI K G, et al. Increased platelet to lymphocyte ratio is related to slow coronary flow[J]. Angiology, 2016, 67(1): 21-26. doi: 10.1177/0003319715574625
[16]	YAYLA Ç, AKBOGA M K, GAYRETLI YAYLA K, et al. A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio[J]. Biomark Med, 2016, 10(5): 485-493. doi: 10.2217/bmm-2016-0022
[17]	YILMAZ M, KORKMAZ H, BILEN M N, et al. Could neutrophil/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow[J]. J Int Med Res, 2016, 44(6): 1443-1453. doi: 10.1177/0300060516664637
[18]	PEKDEMIR H, POLAT G, CIN V G, et al. Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow[J]. Int J Cardiol, 2004, 97(1): 35-41. doi: 10.1016/j.ijcard.2003.06.025
[19]	SEZGIN N, BARUTCU I, SEZGIN A T, et al. Plasma nitric oxide level and its role in slow coronary flow phenomenon[J]. Int Heart J, 2005, 46(3): 373-382. doi: 10.1536/ihj.46.373
[20]	KAYAPINAR O, OZDE C, KAYA A. Relationship between the reciprocal change in inflammation-related biomarkers (fibrinogen-to-albumin and hsCRP-to-albumin ratios) and the presence and severity of coronary slow flow[J]. Clin Appl Thromb Hemost, 2019, 25: 107602961983538. doi: 10.1177/1076029619835383
[21]	TURHAN H, SAYDAM G S, ERBAY A R, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow[J]. Int J Cardiol, 2006, 108(2): 224-230. doi: 10.1016/j.ijcard.2005.05.008
[22]	GUO F M, DONG M, REN F X, et al. Association between local interleukin-6 levels and slow flow/microvascular dysfunction[J]. J Thromb Thrombolysis, 2014, 37(4): 475-482. doi: 10.1007/s11239-013-0974-0
[23]	吴岑岑, 祖凌云, 陈少敏, 等. 急性冠状动脉综合征的发病机制及治疗进展[J]. 中华脑血管病杂志: 电子版, 2021, 15(1): 22-27. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHND202101005.htm
[24]	DING Y D, PEI Y Q, WANG R, et al. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow[J]. BMC Cardiovasc Disord, 2020, 20(1): 248. doi: 10.1186/s12872-020-01463-8
[25]	WANG Y, LIU M J, YANG H M, et al. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon[J]. BMC Cardiovasc Disord, 2018, 18(1): 138. doi: 10.1186/s12872-018-0873-6
[26]	ELAMRAGY A A, ABDELHALIM A A, ARAFA M E, et al. Anxiety and depression relationship with coronary slow flow[J]. PLoS One, 2019, 14(9): e0221918. doi: 10.1371/journal.pone.0221918
[27]	常快乐, 郑龙, 袁建君. 冠状动脉慢血流患者合并焦虑抑郁的临床治疗研究[A]. 2017国际数字医学会数字中医药分会论文集[C]. 长沙: 湖南中医药大学期刊杂志社, 2017: 435-436.
[28]	YE M F, ZHAO Z W, LUO Y K, et al. Elevated endocan concentration is associated with coronary slow flow[J]. Scand J Clin Lab Invest, 2016, 76(5): 345-348. doi: 10.1080/00365513.2016.1177853
[29]	AKYÜZ A, AYDIN F, ALPSOY Ş, et al. Relationship of serum salusin beta levels with coronary slow flow[J]. Anatol J Cardiol, 2019, 22(4): 177-184.
[30]	WANG Y, JIA P Y, CHEN B J, et al. Evaluation of plasma thrombomodulin in patients with coronary slow flow[J]. Cardiology, 2017, 138(3): 141-146. doi: 10.1159/000460239
[31]	ZHU Y T, ZHU L P, WANG Z Y, et al. Plasma choline as a diagnostic biomarker in slow coronary flow[J]. Cardiol Res Pract, 2020, 2020: 7361434.
[32]	TASAL A, BACAKSIZ A, ERTAS G, et al. Association between serum cystatin C levels and coronary slow flow[J]. Angiology, 2014, 65(9): 831-837. doi: 10.1177/0003319713505697
[33]	吴高祥, 楚天舒, 武力勇. 瘦素在冠状动脉慢血流现象中的研究进展[J]. 心血管病学进展, 2016, 37(5): 550-553. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGB201605024.htm

[1]	LI Jia, WANG Lin, LIU Nan, WANG Ting, ZHAO Xiaoya, GAO Lini, ZHAO Ping. Effect of mindfulness training on sleep quality and psychological state of perimenopausal patients with insomnia[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 85-88. DOI: 10.7619/jcmp.20222790
[2]	LIN Yan, ZHOU Ping, LI Yanzhen, LI Shiting. Effect of preoperative anxiety and depression and sleep qualityon sequelae of Bell's palsy and its intervention strategy[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 30-33. DOI: 10.7619/jcmp.20201495
[3]	XI Lijuan, WANG Daorong, FANG Fang, YUAN Haijuan. Mediating effect of depression on sleep and preoperative frailty in elderly patients with gastrointestinal cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 50-54. DOI: 10.7619/jcmp.20201747
[4]	ZHANG Zhanhua, TIAN Feng. Expression of serum cortisol levels in post-stroke depression patients before and after treatment and its correlation with depression[J]. Journal of Clinical Medicine in Practice, 2019, 23(24): 34-36. DOI: 10.7619/jcmp.201924011
[5]	MEI Jing, WANG Chungang, BO Lin. Effect of SSRI anti depression drugs combined with conventional drugs for cerebral vascular disease on treatment of patients with post stroke depression[J]. Journal of Clinical Medicine in Practice, 2017, (1): 25-27. DOI: 10.7619/jcmp.201701007
[6]	CHEN Rende. The effect of duloxetine on sleeping quality of elderly female patients with depression[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 159-160.
[7]	JIA Jing, QIANG Xiaoling. Influence of comprehensive nursing interventions on depressive emotion and QOL in patients with depression[J]. Journal of Clinical Medicine in Practice, 2015, (16): 14-16. DOI: 10.7619/jcmp.201516005
[8]	QIU Yanli. The influence of psychological nursing intervention combined with massage on postpartum depression of patients[J]. Journal of Clinical Medicine in Practice, 2015, (2): 77-79,83. DOI: 10.7619/jcmp.201502024
[9]	Study on the relationship between quality of life and self-efficacy of patients with depressive disorder[J]. Journal of Clinical Medicine in Practice, 2014, (20): 15-18. DOI: 10.7619/jcmp.201420005
[10]	SONG Wenying. Influence of nursing intervention on the quality of life of patients with depression[J]. Journal of Clinical Medicine in Practice, 2013, (16): 147-149. DOI: 10.7619/jcmp.201316057

Cited By

Cited by

Periodical cited type(25)

1.	刘珊励，刘金叶，陈叶奇. 甘精胰岛素与预混胰岛素分别联合阿卡波糖对2型糖尿病患者血糖控制及胰岛素用量的影响. 糖尿病新世界. 2024(15): 91-94 .
2.	佘其美，董亚苒，王新芳，玉晓露，程景丽，裴倩倩，谷贵燕，李湘. 分析甘精胰岛素联合磷酸西格列汀治疗老年2型糖尿病（T2DM）的临床效果. 糖尿病新世界. 2023(04): 116-119+123 .
3.	魏伟. 甘精胰岛素联合重组人胰岛素强化治疗2型糖尿病的临床效果. 临床合理用药. 2023(23): 98-101 .
4.	毛财凤. 甘精胰岛素联合口服降糖药治疗血糖控制不佳的2型糖尿病患者的临床效果. 中国医学创新. 2023(25): 16-20 .
5.	郑清华，时维琼，刘慧丽. 胰岛素联合平衡盐溶液对老年重度糖尿病酮症酸中毒患者β2微球蛋白、FT4水平的影响. 中国老年学杂志. 2022(08): 1816-1819 .
6.	刘利. 利格列汀联合度拉糖肽对2型糖尿病患者临床疗效研究. 天津药学. 2022(02): 63-65+71 .
7.	陈钦榜，何英. 阿卡波糖联合甘精胰岛素对2型糖尿病患者的疗效及不良反应的影响. 糖尿病新世界. 2022(13): 81-84 .
8.	张魁星. 甘精胰岛素联合二甲双胍治疗2型糖尿病的效果分析. 现代诊断与治疗. 2022(18): 2717-2719 .
9.	张子毅，郭静超. 甘精胰岛素联合二甲双胍对初发2型糖尿病患者血糖水平和胰岛β功能的影响. 实用糖尿病杂志. 2021(01): 99-100 .
10.	王利平. 阿卡波糖和胰岛素治疗老年2型糖尿病的效果和安全性. 中国当代医药. 2021(11): 76-78 .
11.	冯聪. 2型糖尿病应用长效胰岛素联合口服降糖药治疗的有效性研究. 中国实用医药. 2021(20): 136-138 .
12.	黄新峰. 2型糖尿病治疗中甘精胰岛素联合瑞格列奈的应用安全性分析. 黑龙江中医药. 2021(04): 35-36 .
13.	房思思. 长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性. 中国实用医药. 2021(27): 114-116 .
14.	汪俊. 甲巯咪唑联合甘精胰岛素对糖尿病伴甲亢的疗效分析. 医学食疗与健康. 2021(08): 58-59 .
15.	李华荣，余婷. 麦味地黄汤加减联合消渴丸治疗2型糖尿病临床效果观察. 现代诊断与治疗. 2021(21): 3380-3381 .
16.	林小玲. 甘精胰岛素联合阿卡波糖治疗老年糖尿病的临床疗效及安全性分析. 中国现代药物应用. 2020(09): 170-171 .
17.	陈维平，谢芸. 沙格列汀联合胰岛素用药在2型糖尿病治疗中的临床作用. 中外医学研究. 2020(15): 136-138 .
18.	何德卓. 甘精胰岛素联合阿卡波糖治疗2型糖尿病临床观察. 北方药学. 2020(06): 104-105 .
19.	张明谦. 甘精胰岛素和预混胰岛素治疗2型糖尿病的临床效果比较. 福建医药杂志. 2020(03): 174-175 .
20.	林玉平. 甘精胰岛素联合门冬胰岛素治疗对T2DM患者的血糖控制效果. 海峡药学. 2020(08): 190-192 .
21.	龙爱梅，武红梅，邓丽萍，黄妙玲，何圣清，张帆. 甘精胰岛素和预混胰岛素分别联合阿卡波糖治疗2型糖尿病效果差异. 中国处方药. 2020(10): 105-106 .
22.	王玲，赵岚. 糖尿病患者阿卡波糖治疗的临床疗效研究进展. 实用心脑肺血管病杂志. 2020(S1): 282-283 .
23.	孙景. 甘精胰岛素联合瑞格列奈治疗2型糖尿病的价值研究. 海峡药学. 2020(10): 155-156 .
24.	张琼珍. 预混胰岛素类似物与基础胰岛素对128例2型糖尿病患者起始胰岛素治疗的临床疗效分析. 糖尿病新世界. 2020(22): 34-36 .
25.	何燕. 基础胰岛素联合阿卡波糖对比预混胰岛素治疗2型糖尿病的临床效果分析. 糖尿病新世界. 2020(24): 94-96 .

Other cited types(0)

Get Citation

PDF

XML

Article views (237) PDF downloads (23) Cited by(25)

Turn off MathJax

Article Contents

Abstract

References

Research progress on risk factors of coronary slow flow

Abstract

References

Related Articles

Cited by

Periodical cited type(25)

Other cited types(0)

Catalog

Research progress on risk factors of coronary slow flow

Abstract

References

Related Articles

Cited by

Periodical cited type(25)

Other cited types(0)

Catalog

Export File

Citation

Format

Content